Most of the fuss raised by the science advocacy community over the changes in European Commission structure focused on the discontinued position of Chief Scientific Adviser. By the end of this year a seven member science advisory board should be in place.
However, the European Group on Ethics in Science and New Technologies (EGE) was in a similar state of limbo following the change in Commission Presidents. It was recently announced that the group will continue as part of the research department, where the science advisory board will also sit.
The EGE has been around since 1991, and currently has five theologians, five lawyers and five scientists as members. Its closest U.S. equivalent appears to be the various bioethical commissions that advised presidential administrations. The work product of the EGE has focused on matters connected to biotechnology, but it is not limited to that area. Recently the EGE has also conducted ethics reviews of grant applications under the Framework Programmes (and presumably their successor, Horizon 2020).